In this Section |
204989 Pregnancy Risk Index: Using behavioral data to predict pregnancy and infertilityMonday, November 9, 2009
Background
The Pregnancy Risk Index (PRI) is a simple mathematical method for calculating pregnancy risk using behavioral data. Method To validate the PRI, we used data from women 15-44 years in the National Survey of Family Growth between 1982 and 2002. PRI scores are calculated based on a woman's sexual activity in the past 3 months, contraception use at last intercourse, and the relative efficacy of method(s) used - based on published contraceptive failure rates. We also reviewed published literature on contraceptive failure rates and infertility by age of woman. Results Published contraceptive failure rates have changed little over 20 years in the U.S. We found that the PRI correlated well with actual pregnancy rates across demographic subgroups (R=.86). The PRI reproduced patterns of pregnancy by age, over time and among racial and ethnic subgroups. The PRI overestimated pregnancy risk among women 35-40 years (~2 fold), and women over 40 (~4 fold), even after adjustment for known infertility. Variation in coital frequency by age did not explain this finding. These data suggest considerable undiagnosed infertility beginning at age 35, approaching infertility estimates from natural fertility populations. Discussion The Pregnancy Risk Index provides a readily calculated method to assess demographic trends and may be useful in evaluating intervention programs and simulating the impact of behavioral changes for women under 35. The PRI method may also be useful in estimating infertility from population data.
Learning Objectives: Keywords: Contraception, Pregnancy
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the principal investigator on this study, reviewed all data analyses, and wrote the abstract I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Messages and Methods in Contraception and Family Planning
See more of: Population, Reproductive and Sexual Health |